from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1879/-

LFCtreatmentdescriptionclass of inhibitor

0.105

Amikacinug/mL Amikacintranslation

-0.621

Cap5-10ug/mL Capreomycintranslation

-0.417

Rox10-50 ug/mL Roxithromycintranslation

0.380

SM2-5 ug/mL Streptomycintranslation

2.003

Tet5-10 ug/mL Tetracyclinetranslation

0.714

Rif0.2-5ug/mL Rifampicintranscription

0.959

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.131

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.392

CPZ10-50 ug/mL Chlorpromazinerespiration

1.574

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.277

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.433

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.034

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.624

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.000

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.653

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.735

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.264

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.234

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.674

KCN5-20 ug/mL Potassium cyaniderespiration

-0.886

NaN30.2-2 mM Sodium aziderespiration

-1.288

Nigericin50 uM Nigericinrespiration

0.087

TRC10-150 ug/mL Triclosanrespiration

1.480

TRZ10-25 ug/mL Thioridazinerespiration

-1.934

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-2.428

menadione6-10 ug/mL Menadionerespiration

0.031

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.355

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.353

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.234

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.587

NRP_1Non-replicating persistence stage 1dosRassociated

-0.791

Amp0.2mg/mL AmpicillincellWall

0.211

Cephalexin20-100 ug/mL CephalexincellWall

0.504

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.569

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.382

EMB10-20 ug/mL EthambutolcellWall

0.975

Eta12-40 ug/mL EthionamidecellWall

-0.193

INH0.2-0.4 ug/mL IsoniazidcellWall

0.413

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.675

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.614

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.087

BZA0.12 mg/mL BenzamidearomaticAmides

0.333

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.093

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.134

H2O24 mM hydrogen peroxideDNAdamaging

-0.244

Levo10 ug/mL LevofloxacinDNAdamaging

0.297

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.152

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.453

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.309

UVUV-irradiationDNAdamaging

0.065

ARP41-4 ug/mL Antitubercular compound ARP4?

0.222

Antimycin12.5-50 ug/mL Antimycin A?

-1.323

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.145

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.139

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.509

PA8240.2-2 ug/mL PA-824?

-0.328

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.173

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.974

Verapamil50 uM Verapamil?

-1.674

mercaptoethanol2 mM 2-Mercaptoethanol?

0.071

methoxatin10-20 ug/mL Methoxatin?